购物车
- 全部删除
- 您的购物车当前为空
CYP3A4-IN-4(compound Δ,Λ-3)是一个结合了Ru(II)与Ir(III)的化合物,能作为人体主要的药物代谢酶CYP3A4的光活性抑制剂使用。这种化合物包含了[Ru(tpy)(Me2bpy)]的光笼结构群,在经过光照处理(λirr=530 nm,tirr=15 min)后,其对微粒体CYP3A4的抑制半数最大效应浓度(IC50)为2.2 μM。此外,CYP3A4-IN-4的光治疗指数(PI)达到5.4。
CYP3A4-IN-4(compound Δ,Λ-3)是一个结合了Ru(II)与Ir(III)的化合物,能作为人体主要的药物代谢酶CYP3A4的光活性抑制剂使用。这种化合物包含了[Ru(tpy)(Me2bpy)]的光笼结构群,在经过光照处理(λirr=530 nm,tirr=15 min)后,其对微粒体CYP3A4的抑制半数最大效应浓度(IC50)为2.2 μM。此外,CYP3A4-IN-4的光治疗指数(PI)达到5.4。
产品描述 | CYP3A4-IN-4 (compound Δ,Λ-3) constitutes a Ru(II)-Ir(III) complex that acts as a photoactive inhibitor of the primary human drug-metabolizing enzyme CYP3A4. This complex features a [Ru(tpy)(Me2bpy)] photocaging group and exhibits an IC50 of 2.2 μM for the inhibition of microsomal CYP3A4 under irradiation conditions (λirr=530 nm, tirr=15 min). The phototherapeutic index (PI) of CYP3A4-IN-4 is 5.4. |
分子量 | 516.52 |
分子式 | C22H22F2N8O3S |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容